Scenarios that move INCY
Incyte Corporation - Common Stock
Scenarios that move INCY: 4 analyses, 1 positive, 3 negative.
- · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▼ · impact -14 · confidence medium · horizon immediate
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▼ · impact -16 · confidence low · horizon quarters
- · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▼ · impact -28 · confidence medium · horizon quarters
- · Ascendis announces planned $400 million share repurchase program — ▲ · impact +11 · confidence low · horizon quarters